LE WE PMID CA
Addiction (BASKET)2641Sucht (allg)

Acamprosate

Addiction (BASKET)

ADHD

Amygdala

Arousal (Neurophysiology)

Basal ganglia

BDNF

Bird

Buprenorphin

Cannabis

Coffein

Cognitive enhancer

Conditioned place preference

Conditioning (Neurophysiology)

CRH Corticotropin releasing hormone

Decision (Neurophysiology)

Dynorphin

Endocannabinoid

Endophenotype

ERS UFR (Diseases)

Extinction learning

Fetal alcohol syndrome

Gabapentin

Galanin

Glutamate (Neurotransmitter)

Heroin

Hippocampus

Homer

Laboratory animal (Zebrafish)

Lamotrigine

Learning and memory (Neurophysiology)

Leptin

Memantine

Methadone

Modafinil

N Acetylcysteine

Neurodegeneration

Nociceptin

Nutrition (Neuroendocrinology)

Obsessive compulsive disorder

Orbitofrontal cortex

Orexin

Psychosurgery

Raphe

Receptor (Acetylcholine nicotinic)

Receptor (Adenosine)

Receptor (Glutamate)

Receptor (Opiate kappa)

Reward (Neurophysiology)

Sport medical aspects

Stress (Neurophysiology)

Sugar

Tegmentum

Teratogenesis

Topiramate

Ventral tegmental area

Vocalization (Animal)

2008  
1
Desire, disease, and the origins of the dopaminergic system.
[18283047] Schizophr Bull 34(2): 212-9 (2008)
1999  
2
Drugs of abuse and brain gene expression.
[10511013] Psychosom Med 61(5): 630-50 (1999)
2006  
3
The mechanistic classification of addictive drugs.
[17105338] PLoS Med 3(11): e437 (2006)
1996  
4
Withdrawal strategies for outpatients. Alcohol, benzodiazepine, barbiturate, and opiate addictions.
[8828877] Can Fam Physician 42(-): 1745-52 (1996)
2005  
5
Substance use disorders and the orbitofrontal cortex: systematic review of behavioural decision-making and neuroimaging studies.
[16135857] Br J Psychiatry 187(-): 209-20 (2005)
2003  
6
Neurobiology of addiction and implications for treatment.
[12562734] Br J Psychiatry 182(-): 97-100 (2003)
2005  
7
Behavioral therapies for drug abuse.
[16055766] Am J Psychiatry 162(8): 1452-60 (2005)
2005  
8
Medication development for addictive disorders: the state of the science.
[16055764] Am J Psychiatry 162(8): 1432-40 (2005)
2005  
9
Anticraving medications for relapse prevention: a possible new class of psychoactive medications.
[16055763] Am J Psychiatry 162(8): 1423-31 (2005)
2005  
10
Addiction: a disease of learning and memory.
[16055762] Am J Psychiatry 162(8): 1414-22 (2005)
2005  
11
The neural basis of addiction: a pathology of motivation and choice.
[16055761] Am J Psychiatry 162(8): 1403-13 (2005)
2005  
12
What do we know about drug addiction?
[16055760] Am J Psychiatry 162(8): 1401-2 (2005)
2002  
13
Drug addiction and its underlying neurobiological basis: neuroimaging evidence for the involvement of the frontal cortex.
[12359667] Am J Psychiatry 159(10): 1642-52 (2002)
2005  
14
Behavioral perspectives on the neuroscience of drug addiction.
[16596985] J Exp Anal Behav 84(3): 667-81 (2005)
2005  
15
Neuronal substrates of relapse to cocaine-seeking behavior: role of prefrontal cortex.
[16596984] J Exp Anal Behav 84(3): 653-66 (2005)
2007  
16
Assessing addiction: concepts and instruments.
[18292706] Addict Sci Clin Pract 4(1): 19-31 (2007)
2004  
17
Extinction training regulates neuroadaptive responses to withdrawal from chronic cocaine self-administration.
[15466321] Learn Mem 11(5): 648-57 (2004)
2002  
18
GABAergic mechanisms of opiate reinforcement .
[12217944] Alcohol Alcohol 37(5): 485-94 (2002)
2008  
19
A role for brain stress systems in addiction.
[18614026] Neuron 59(1): 11-34 (2008)
2008  
20
Cocaine-paired cues activate aversive representations in accumbens neurons.
[18341985] Neuron 57(5): 633 (2008)
2004  
21
Memory and addiction: shared neural circuitry and molecular mechanisms.
[15450168] Neuron 44(1): 161-79 (2004)
2002  
22
Banburismus and the brain: decoding the relationship between sensory stimuli, decisions, and reward.
[12383783] Neuron 36(2): 299-308 (2002)
2002  
23
Reward, motivation, and reinforcement learning.
[12383782] Neuron 36(2): 285-98 (2002)
2002  
24
Getting formal with dopamine and reward.
[12383780] Neuron 36(2): 241-63 (2002)
2002  
25
Brain reward circuitry: insights from unsensed incentives.
[12383779] Neuron 36(2): 229-40 (2002)
2002  
26
Experimental genetic approaches to addiction.
[12383778] Neuron 36(2): 213-28 (2002)
2002  
27
The need to feed: homeostatic and hedonic control of eating.
[12383777] Neuron 36(2): 199-211 (2002)
2002  
28
1998  
29
Neuroscience of addiction.
[9768834] Neuron 21(3): 467-76 (1998)
2008  
30
The role of acetylcholine in cocaine addiction.
[17928814] Neuropsychopharmacology 33(8): 1779-97 (2008)
2007  
31
There and back again: a tale of norepinephrine and drug addiction.
[17164822] Neuropsychopharmacology 32(7): 1433-51 (2007)
2001  
32
Drug addiction, dysregulation of reward, and allostasis.
[11120394] Neuropsychopharmacology 24(2): 97-129 (2001)
2008  
33
Regulation of psychostimulant-induced signaling and gene expression in the striatum.
[18221378] J Neurochem 104(6): 1440-9 (2008)
2007  
34
Pharmacologic treatments for opioid dependence: detoxification and maintenance options.
[18286804] Dialogues Clin Neurosci 9(4): 455-70 (2007)
2007  
35
Pharmacogenetic aspects of addictive behaviors.
[18286803] Dialogues Clin Neurosci 9(4): 447-54 (2007)
2007  
36
Therapeutic options and challenges for substances of abuse.
[18286802] Dialogues Clin Neurosci 9(4): 431-45 (2007)
2007  
37
Opioids, dopamine, stress, and the addictions.
[18286797] Dialogues Clin Neurosci 9(4): 363-78 (2007)
2007  
38
Historical and cultural aspects of man's relationship with addictive drugs.
[18286796] Dialogues Clin Neurosci 9(4): 355-61 (2007)
2006  
39
Neurorobiology and evidence-based biological treatments for substance abuse disorders.
[17075558] CNS Spectr 11(11): 864-77 (2006)
2006  
40
Perspectives on current directions in the neurobiology of addiction disorders relevant to genetic risk factors.
[17075557] CNS Spectr 11(11): 855-62 (2006)
2006  
41
The application of mindfulness-based cognitive interventions in the treatment of co-occurring addictive and mood disorders.
[17075556] CNS Spectr 11(11): 829-51 (2006)
2003  
42
Ultrarapid opiate detoxification: a review.
[12944440] Can J Anaesth 50(7): 663-71 (2003)
2008  
43
The cholinergic mesopontine tegmentum is a relatively neglected nicotinic master modulator of the dopaminergic system: relevance to drugs of abuse and pathology.
[18223661] Br J Pharmacol 153 Suppl 1(-): S438-45 (2008)
2008  
44
Addiction: the clinical interface.
[18414399] Br J Pharmacol 154(2): 397-405 (2008)
2005  
45
Pharmacogenetics and human molecular genetics of opiate and cocaine addictions and their treatments.
[15734726] Pharmacol Rev 57(1): 1-26 (2005)
2002  
46
Neurobiology of relapse to heroin and cocaine seeking: a review.
[11870259] Pharmacol Rev 54(1): 1-42 (2002)
2001  
47
The role of corticotropin-releasing factor in drug addiction.
[11356984] Pharmacol Rev 53(2): 209-43 (2001)
1999  
48
Actions of caffeine in the brain with special reference to factors that contribute to its widespread use.
[10049999] Pharmacol Rev 51(1): 83-133 (1999)
2008  
49
2008  
50
Review. Neurobiological mechanisms for opponent motivational processes in addiction.
[18653439] Philos Trans R Soc Lond B Biol Sci 363(1507): 3113-23 (2008)
2008  
51
Review. Transcriptional mechanisms of addiction: role of DeltaFosB.
[18640924] Philos Trans R Soc Lond B Biol Sci 363(1507): 3245-55 (2008)
2008  
52
Review. Positron emission tomography imaging studies of dopamine receptors in primate models of addiction.
[18640923] Philos Trans R Soc Lond B Biol Sci 363(1507): 3223-32 (2008)
2008  
53
Review. Context-induced relapse to drug seeking: a review.
[18640922] Philos Trans R Soc Lond B Biol Sci 363(1507): 3233-43 (2008)
2008  
54
Review. Psychological and neural mechanisms of relapse.
[18640921] Philos Trans R Soc Lond B Biol Sci 363(1507): 3147-58 (2008)
2008  
55
Review. The incentive sensitization theory of addiction: some current issues.
[18640920] Philos Trans R Soc Lond B Biol Sci 363(1507): 3137-46 (2008)
2008  
56
2008  
57
Review. Genetics of addictions: strategies for addressing heterogeneity and polygenicity of substance use disorders.
[18640915] Philos Trans R Soc Lond B Biol Sci 363(1507): 3213-22 (2008)
2008  
58
2008  
59
Review. Neural mechanisms underlying the vulnerability to develop compulsive drug-seeking habits and addiction.
[18640910] Philos Trans R Soc Lond B Biol Sci 363(1507): 3125-35 (2008)
2008  
60
Review. The neurobiology of pathological gambling and drug addiction: an overview and new findings.
[18640909] Philos Trans R Soc Lond B Biol Sci 363(1507): 3181-9 (2008)
1992  
61
2008  
62
The neurosurgical treatment of addiction.
[18590382] Neurosurg Focus 25(1): E5 (2008)
1997  
63
Molecular and cellular basis of addiction.
[9311927] Science 278(5335): 58-63 (1997)
2010  
64
Evaluation of motivational effects induced by intracranial self-stimulation behavior.
[20975759] Acta Med Okayama 64(5): 267-75 (2010)
2011  
65
Inhalant use and inhalant use disorders in the United States.
[22003419] Addict Sci Clin Pract 6(1): 18-31 (2011)
2009  
66
Anabolic-androgenic steroid dependence: an emerging disorder.
[19922565] Addiction 104(12): 1966-78 (2009)
2007  
67
A vision of the next generation of behavioral therapies research in the addictions.
[17523974] Addiction 102(6): 850-62; discussion 863-9 (2007)
2009  
68
Behavioral intervention to promote smoking cessation and prevent weight gain: a systematic review and meta-analysis.
[19549058] Addiction 104(9): 1472-86 (2009)
2002  
69
Drug addiction as drive satisfaction ("antidrive") dysfunction.
[12201032] Acta Neurobiol Exp (Wars) 62(2): 111-7 (2002)
2010  
70
Waterpipe tobacco smoking: an emerging health crisis in the United States.
[20001185] Am J Health Behav 34(3): 275-85 (2010)
2008  
71
Neurobiological processes in adolescent addictive disorders.
[18214718] Am J Addict 17(1): 6-23 (2008)
2009  
72
Pharmacogenetic treatments for drug addiction: cocaine, amphetamine and methamphetamine.
[19462300] Am J Drug Alcohol Abuse 35(3): 161-77 (2009)
2003  
73
A new anatomical framework for neuropsychiatric disorders and drug abuse.
[14514480] Am J Psychiatry 160(10): 1726-39 (2003)
2003  
74
Predisposition to addiction: pharmacokinetics, pharmacodynamics, and brain circuitry.
[12505792] Am J Psychiatry 160(1): 1-2 (2003)
2007  
75
2008  
76
Conditioned place preference induced by licit drugs: establishment, extinction, and reinstatement.
[19082419] ScientificWorldJournal 8(-): 1228-45 (2008)
2006  
77
Role of brain dopamine in food reward and reinforcement.
[16874930] Philos Trans R Soc Lond B Biol Sci 361(1471): 1149-58 (2006)
2010  
78
Androgen abuse in athletes: detection and consequences.
[20139230] J Clin Endocrinol Metab 95(4): 1533-43 (2010)
2008  
79
Neuropsychotoxicity of abused drugs: molecular and neural mechanisms of neuropsychotoxicity induced by methamphetamine, 3,4-methylenedioxymethamphetamine (ecstasy), and 5-methoxy-N,N-diisopropyltryptamine (foxy).
[18198474] J Pharmacol Sci 106(1): 2-8 (2008)
2008  
80
Neuropsychotoxicity of abused drugs: effects of serotonin receptor ligands on methamphetamine- and cocaine-induced behavioral sensitization in mice.
[18198473] J Pharmacol Sci 106(1): 15-21 (2008)
2008  
81
Neuropsychotoxicity of abused drugs: involvement of matrix metalloproteinase-2 and -9 and tissue inhibitor of matrix metalloproteinase-2 in methamphetamine-induced behavioral sensitization and reward in rodents.
[18198472] J Pharmacol Sci 106(1): 9-14 (2008)
2008  
82
A neuropeptide-centric view of psychostimulant addiction.
[18414383] Br J Pharmacol 154(2): 343-57 (2008)
2008  
83
Genetic factors influencing alcohol dependence.
[18362899] Br J Pharmacol 154(2): 275-87 (2008)
2008  
84
Inhalant abuse among adolescents: neurobiological considerations.
[18332858] Br J Pharmacol 154(2): 316-26 (2008)
2003  
85
The addicted human brain: insights from imaging studies.
[12750391] J Clin Invest 111(10): 1444-51 (2003)
2007  
86
Intense sweetness surpasses cocaine reward.
[17668074] PLoS One 2(8): e698 (2007)
2011  
87
The epigenetic landscape of addiction.
[21272014] Ann N Y Acad Sci 1216(-): 99-113 (2011)
2011  
88
Hippocampus, amygdala, and stress: interacting systems that affect susceptibility to addiction.
[21272015] Ann N Y Acad Sci 1216(-): 114-21 (2011)
2010  
89
Synaptic plasticity in the mesolimbic system: therapeutic implications for substance abuse.
[20201850] Ann N Y Acad Sci 1187(-): 129-39 (2010)
2010  
90
Neurochemistry of drug action: insights from proton magnetic resonance spectroscopic imaging and their relevance to addiction.
[20201852] Ann N Y Acad Sci 1187(-): 148-71 (2010)
2009  
91
Molecular mechanisms of psychostimulant addiction.
[19403004] Chang Gung Med J 32(2): 148-54 (2009)
2008  
92
A 50-year-old woman addicted to heroin: review of treatment of heroin addiction.
[18594026] JAMA 300(3): 314-21 (2008)
2008  
93
Addiction and substance abuse in anesthesiology.
[18946304] Anesthesiology 109(5): 905-17 (2008)
2006  
94
Animal models and brain circuits in drug addiction.
[17200461] Mol Interv 6(6): 339-44 (2006)
2011  
95
Buprenorphine: new treatment of opioid addiction in primary care.
[21402963] Can Fam Physician 57(3): 281-9 (2011)
2003  
96
Managing opioid dependence. Comparing buprenorphine with methadone.
[12901482] Can Fam Physician 49(-): 876-7 (2003)
2008  
97
New insights on the subcortical representation of reward.
[18674617] Curr Opin Neurobiol 18(2): 203-8 (2008)
2007  
98
Dynorphin and the pathophysiology of drug addiction.
[17868902] Pharmacol Ther 116(2): 306-21 (2007)
2009  
99
Anti-relapse medications: preclinical models for drug addiction treatment.
[19683019] Pharmacol Ther 124(2): 235-47 (2009)
2008  
100
Behavioral characteristics and neurobiological substrates shared by Pavlovian sign-tracking and drug abuse.
[18234349] Brain Res Rev 58(1): 121-35 (2008)
2010  
101
A ventral tegmental CRF-glutamate-dopamine interaction in addiction.
[19800323] Brain Res 1314(-): 38-43 (2010)
2010  
102
Molecular and genetic substrates linking stress and addiction.
[19900417] Brain Res 1314(-): 219-34 (2010)
2010  
103
The role of CRF and CRF-related peptides in the dark side of addiction.
[19912996] Brain Res 1314(-): 3-14 (2010)
2010  
104
Drug-induced and genetic alterations in stress-responsive systems: Implications for specific addictive diseases.
[19914222] Brain Res 1314(-): 235-52 (2010)
2010  
105
Role of innate and drug-induced dysregulation of brain stress and arousal systems in addiction: Focus on corticotropin-releasing factor, nociceptin/orphanin FQ, and orexin/hypocretin.
[20026088] Brain Res 1314(-): 145-61 (2010)
2010  
106
Role of CRF and other neuropeptides in stress-induced reinstatement of drug seeking.
[19631614] Brain Res 1314(-): 15-28 (2010)
2010  
107
Effects of galanin on monoaminergic systems and HPA axis: Potential mechanisms underlying the effects of galanin on addiction- and stress-related behaviors.
[19699187] Brain Res 1314(-): 206-18 (2010)
2010  
108
Role of orexin/hypocretin in dependence and addiction.
[19699189] Brain Res 1314(-): 130-8 (2010)
2010  
109
The dynorphin/kappa opioid system as a modulator of stress-induced and pro-addictive behaviors.
[19716811] Brain Res 1314(-): 44-55 (2010)
2010  
110
Brain-derived neurotrophic factor and cocaine addiction.
[19732758] Brain Res 1314(-): 183-93 (2010)
2010  
111
Corticotropin-releasing factor in the dorsal raphe nucleus: Linking stress coping and addiction.
[19800322] Brain Res 1314(-): 29-37 (2010)
2009  
112
Brain stress systems in the amygdala and addiction.
[19332030] Brain Res 1293(-): 61-75 (2009)
2006  
113
Cannabis use by children and young people.
[16861487] Arch Dis Child 91(8): 692-5 (2006)
2011  
114
Linking cocaine to endoplasmic reticulum in striatal neurons: role of glutamate receptors.
[21808746] Basal Ganglia 1(2): 59-63 (2011)
2008  
115
Homers regulate drug-induced neuroplasticity: implications for addiction.
[17765204] Biochem Pharmacol 75(1): 112-33 (2008)
2008  
116
The neurobiology and genetics of impulse control disorders: relationships to drug addictions.
[17719013] Biochem Pharmacol 75(1): 63-75 (2008)
2008  
117
Glutamatergic substrates of drug addiction and alcoholism.
[17706608] Biochem Pharmacol 75(1): 218-65 (2008)
2008  
118
Genetics of nicotinic acetylcholine receptors: Relevance to nicotine addiction.
[17632086] Biochem Pharmacol 75(1): 323-33 (2008)
2008  
119
Update in addiction medicine for the primary care clinician.
[18830761] J Gen Intern Med 23(12): 2112-6 (2008)
2007  
120
Role of endocannabinoids in regulating drug dependence.
[19300605] Neuropsychiatr Dis Treat 3(6): 711-21 (2007)
2010  
121
2009  
122
Poor response inhibition: at the nexus between substance abuse and attention deficit/hyperactivity disorder.
[18789354] Neurosci Biobehav Rev 33(5): 690-8 (2009)
2010  
123
Role of orexin/hypocretin in reward-seeking and addiction: implications for obesity.
[20338186] Physiol Behav 100(5): 419-28 (2010)
2009  
124
Development of pharmacotherapies for drug addiction: a Rosetta stone approach.
[19483710] Nat Rev Drug Discov 8(6): 500-15 (2009)
2007  
125
Modulation of the endocannabinoid system: therapeutic potential against cocaine dependence.
[17945506] Pharmacol Res 56(5): 406-17 (2007)
2008  
126
Endogenous modulators for drug dependence.
[18758051] Biol Pharm Bull 31(9): 1635-8 (2008)
2010  
127
The effects of waterpipe tobacco smoking on health outcomes: a systematic review.
[20207606] Int J Epidemiol 39(3): 834-57 (2010)
2010  
128
Animal models of substance abuse and addiction: implications for science, animal welfare, and society.
[20579432] Comp Med 60(3): 177-88 (2010)
2010  
129
Neurobiological mechanisms of addiction: focus on corticotropin-releasing factor.
[20047160] Curr Opin Investig Drugs 11(1): 63-71 (2010)
2011  
130
Cognitive enhancers in the treatment of substance use disorders: clinical evidence.
[21557964] Pharmacol Biochem Behav 99(2): 285-94 (2011)
2007  
131
Some rewarding effects of androgens may be mediated by actions of its 5alpha-reduced metabolite 3alpha-androstanediol.
[17112575] Pharmacol Biochem Behav 86(2): 354-67 (2007)
2010  
132
Evidence for opioid involvement in the motivation to sing.
[19995531] J Chem Neuroanat 39(2): 141-50 (2010)
2007  
133
Imaging the addicted human brain.
[17514067] Sci Pract Perspect 3(2): 4-16 (2007)
2009  
134
Dynamics of neuronal circuits in addiction: reward, antireward, and emotional memory.
[19434554] Pharmacopsychiatry 42 Suppl 1(-): S32-41 (2009)
2011  
135
Relapse prevention for addictive behaviors.
[21771314] Subst Abuse Treat Prev Policy 6(-): 17 (2011)
2010  
136
Treatment of anabolic-androgenic steroid dependence: Emerging evidence and its implications.
[20188494] Drug Alcohol Depend 109(1-3): 6-13 (2010)
2004  
137
Neurobiologic processes in drug reward and addiction.
[15764467] Harv Rev Psychiatry 12(6): 305-20 (2004)
2007  
138
Adenosine A2A receptors in ventral striatum, hypothalamus and nociceptive circuitry implications for drug addiction, sleep and pain.
[17532111] Prog Neurobiol 83(5): 332-47 (2007)
2010  
139
Substance use disorders: do males and females have differential vulnerability?
[20686131] J Neuropsychiatry Clin Neurosci 22(3): iv (2010)
2010  
140
Use of zebrafish as a model to understand mechanisms of addiction and complex neurobehavioral phenotypes.
[20493262] Neurobiol Dis 40(1): 66-72 (2010)
2010  
141
2010  
142
2011  
143
The striatal balancing act in drug addiction: distinct roles of direct and indirect pathway medium spiny neurons.
[21811439] Front Neuroanat 5(-): 41 (2011)
2008  
144
Anabolic-androgenic steroid dependence? Insights from animals and humans.
[18275992] Front Neuroendocrinol 29(4): 490-506 (2008)
2010  
145
Structural, metabolic, and functional brain abnormalities as a result of prenatal exposure to drugs of abuse: evidence from neuroimaging.
[20978945] Neuropsychol Rev 20(4): 376-97 (2010)
2007  
146
Theory-based processes that promote the remission of substance use disorders.
[17254686] Clin Psychol Rev 27(5): 537-51 (2007)
2011  
147
Advances in adolescent substance abuse treatment.
[21701838] Curr Psychiatry Rep 13(5): 416-21 (2011)
2008  
148
Novel medications to treat addictive disorders.
[18803912] Curr Psychiatry Rep 10(5): 392-8 (2008)
2005  
149
Psychiatric complications of anabolic steroid abuse.
[16000671] Psychosomatics 46(4): 285-90 (2005)
2010  
150
The role of the dynorphin-kappa opioid system in the reinforcing effects of drugs of abuse.
[20352414] Psychopharmacology (Berl) 210(2): 121-35 (2010)
2008  
151
Serotonergic mechanisms in addiction-related memories.
[18639587] Behav Brain Res 195(1): 39-53 (2008)
2008  
152
The role of orbitofrontal cortex in drug addiction: a review of preclinical studies.
[17719014] Biol Psychiatry 63(3): 256-62 (2008)
2011  
153
2009  
154
Vaccines against morphine/heroin and its use as effective medication for preventing relapse to opiate addictive behaviors.
[19242094] Hum Vaccin 5(4): 214-29 (2009)
2009  
155
Development of active and passive human vaccines to treat methamphetamine addiction.
[19276653] Hum Vaccin 5(4): 206-13 (2009)
2009  
156
Vaccines for cocaine abuse.
[19276665] Hum Vaccin 5(4): 194-9 (2009)
2009  
157
Neurobehavioral effects of acute exposure to four solvents: meta-analyses.
[19339666] Toxicol Sci 109(2): 296-305 (2009)
2010  
158
2010  
159
Glutamatergic targets for enhancing extinction learning in drug addiction.
[21629446] Curr Neuropharmacol 8(4): 394-408 (2010)

Downloaded from http://www.kidney.de - The Database of Free Medical Reviews - The Metatextbook of Medicine - Ossip Groth

All Medline data shown were primarily retrieved from MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.



Search PubMed and many other databases on the combined search terms

GG: addiction

  • Sucht (allg)

  • The BDOM Bibliographic Dictionary of Medicine is a curated collection of free medical articles tagged to concepts.
    Contents until 2011 are reviews from PubMed, contents flagged 'PMC' are regular articles from PubMed Central.
    Search BDOM
    Nephrology Collection
    Radiology Locator

    PubMedCentral monthly collection of free medical articles by major subject

    The framed wikipedia articles are from en.wikipedia.org and they are the actual versions; the first is from Nephropedia